2 × Phanta Max Master Mix (Dye Plus) P525
Vazyme 2 × Phanta Max Master Mix (catalog No. P515), which greatly improves the ability of long fragment amplification, amplification specificity and amplification yield.
Vazyme 2 × Phanta Max Master Mix (catalog No. P515), which greatly improves the ability of long fragment amplification, amplification specificity and amplification yield.
Vazyme 2 × Phanta Max Master Mix (catalog No. P515) is a new generation superior enzyme based on Phanta DNA Polymerase for robust PCR with higher fidelity.
Vazyme 0.2 ml 8-Tube PCR Strips (with Caps) (catalog No. PCR00802-EN) is a disposable molecular experimental consumable specifically for PCR and qPCR experiments.
Vazyme 0.1 ml 8-Tube PCR Strips (with Caps) (catalog No. PCR00801-EN) is a disposable molecular experimental consumable specifically for PCR and qPCR experiments.
DLAB Bottle Top Dispenser DispensMate -Without Brown reagent bottle (2.5-25ml) (7032100103) is Excellent chemical resistance, Inert and high strength components made of PTFE, FEP, BSG, PP.
DLAB Bottle Top Dispenser DispensMate -Without Brown reagent bottle (1-10ml) (7032100102) is Excellent chemical resistance, Inert and high strength components made of PTFE, FEP, BSG, PP.
DLAB Bottle Top Dispenser DispensMate -Without Brown reagent bottle (0.5-5ml) (7032100101) is Excellent chemical resistance, Inert and high strength components made of PTFE, FEP, BSG, PP.
Atezolizumab Biosimilar, Human PD-L1 Monoclonal Antibody. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.
Vazyme Phanta Max Super-Fidelity DNA Polymerase (catalog No. P505) of the fidelity is 128 times that of Taq DNA Polymerase; The amplification speed is 4-150 times that of conventional polymerase.
Atezolizumab Biosimilar, Human IgG4 S228P Mutant. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.